The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of benign versus malignant renal tumors in selected studies.
Paul Russo
No relevant relationships to disclose
Robert G. Uzzo
No relevant relationships to disclose
William Thomas Lowrance
Honoraria - Xcenda
Aviva Asnis-Alibozek
Employment or Leadership Position - IBA Molecular
Norman David LaFrance
Employment or Leadership Position - IBA Molecular
John A. Libertino
No relevant relationships to disclose
Daniel A. Pryma
Honoraria - IBA Molecular
Chaitanya R. Divgi
Consultant or Advisory Role - WILEX AG